Literature DB >> 15116269

Intravenous Iloprost treatment for severe bone pain caused by sickle cell crisis.

Alexander Carl Disch1, Georg Matziolis, Petra Reinke, Carsten Perka.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15116269

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  5 in total

1.  Efficiency of iloprost treatment for osseous malperfusion.

Authors:  Marcus Jäger; Christoph Zilkens; Bernd Bittersohl; Travis Matheney; Gordana Kozina; Dirk Blondin; Rüdiger Krauspe
Journal:  Int Orthop       Date:  2010-03-21       Impact factor: 3.075

Review 2.  [Pain management in non-juvenile, aseptic osteonecrosis].

Authors:  M Jäger; A Werner; S Lentrodt; U Mödder; R Krauspe
Journal:  Schmerz       Date:  2004-12       Impact factor: 1.107

Review 3.  Aseptic osteonecrosis of the hip in the adult: current evidence on conservative treatment.

Authors:  Raymond Klumpp; Carlo Trevisan
Journal:  Clin Cases Miner Bone Metab       Date:  2016-04-07

4.  Short-Term Outcome and MRI Changes in Three Adult Patients with Sickle Cell Disease and Aseptic Osteonecrosis after Treatment with Hyperbaric Oxygen Therapy: A Preliminary Report.

Authors:  Amr Shier; Mohamed Abdelrazek; Ashraf Soliman; Vincenzo De Sanctis; Ahmed Elsayed; Mohamed Abdulla; Shehab Mohamed; Khadra Yassin; Ilham Bilal; Mohamed Yassin
Journal:  Case Rep Oncol       Date:  2020-04-02

5.  Rationale for prostaglandin I2 in bone marrow oedema--from theory to application.

Authors:  Marcus Jäger; Frank Peter Tillmann; Thomas S Thornhill; Marcus Mahmoudi; Dirk Blondin; Gerd Rüdiger Hetzel; Christoph Zilkens; Rüdiger Krauspe
Journal:  Arthritis Res Ther       Date:  2008-10-03       Impact factor: 5.156

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.